Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$16.25 - $21.51 $351,406 - $465,153
-21,625 Closed
0 $0
Q1 2021

May 10, 2021

BUY
$17.92 - $25.86 $387,520 - $559,222
21,625 New
21,625 $395,000

Others Institutions Holding OYST

About Oyster Point Pharma, Inc.


  • Ticker OYST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,831,500
  • Description
  • Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...
More about OYST
Track This Portfolio

Track Adams Street Partners LLC Portfolio

Follow Adams Street Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adams Street Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adams Street Partners LLC with notifications on news.